What is the recommended dose and duration of ceftriaxone (Ceftriaxone) treatment for bacterial infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone Dosage and Duration Guidelines

The recommended dose of ceftriaxone for most bacterial infections is 1-2 grams intravenously or intramuscularly once daily for 7-14 days, with specific dosing and duration determined by the type and severity of infection. 1

Dosage Recommendations by Infection Type

Adults:

  • Standard adult daily dose: 1-2 grams once daily (or divided twice daily for severe infections)
  • Maximum daily dose: 4 grams
  • Uncomplicated gonorrhea: 500 mg IM as a single dose 2
  • Surgical prophylaxis: 1 gram IV 30-120 minutes before surgery 1

Pediatric patients:

  • Skin/soft tissue infections: 50-75 mg/kg once daily (maximum 2 grams/day)
  • Serious infections (non-meningitis): 50-75 mg/kg divided every 12 hours (maximum 2 grams/day)
  • Meningitis: 100 mg/kg initially (maximum 4 grams), then 100 mg/kg/day once daily or divided every 12 hours (maximum 4 grams/day) 1
  • Acute otitis media: 50 mg/kg IM as a single dose (maximum 1 gram) 1

Duration of Treatment

Duration varies by infection type:

  • Standard duration: 4-14 days 1
  • Complicated infections: May require longer therapy
  • Streptococcal infections: Minimum 10 days 1
  • Bacterial meningitis: 7-14 days (10-14 days if meningitis is documented) 3, 4
  • Infective endocarditis: 4-6 weeks 3
  • Gonorrhea: Single dose 2

Special Considerations

Pharyngeal Gonorrhea

For pharyngeal gonorrhea, a higher dose of 500 mg is required as lower doses may lead to treatment failure. Test-of-cure is recommended 7-14 days after treatment 2.

Neonates and Infants

  • Gonococcal ophthalmia: 25-50 mg/kg IV/IM as a single dose (not to exceed 125 mg) 3
  • Disseminated gonococcal infection: 25-50 mg/kg/day IV/IM for 7 days (10-14 days for meningitis) 3
  • Administer IV doses over 60 minutes in neonates to reduce the risk of bilirubin encephalopathy 1

Administration Routes

  • Intramuscular: Inject well within a large muscle after reconstitution
  • Intravenous: Administer over 30 minutes (60 minutes for neonates) 1

Efficacy and Safety

Ceftriaxone once-daily dosing has been shown to be as effective as more frequent dosing regimens for most infections 5, 6. A recent study comparing 1 gram versus 2 grams daily for bacteremia showed no significant difference in clinical failure rates between the two dosing regimens 7.

Important Precautions

  • Do not use diluents containing calcium (e.g., Ringer's solution)
  • Incompatible with vancomycin, amsacrine, aminoglycosides, and fluconazole in admixtures
  • Use cautiously in hyperbilirubinemic infants, especially premature ones 3, 1
  • If Chlamydia trachomatis is suspected, add appropriate antichlamydial coverage 1

Common Pitfalls to Avoid

  1. Underdosing for pharyngeal infections
  2. Inadequate duration for streptococcal infections (should be at least 10 days)
  3. Failing to adjust infusion time for neonates (should be 60 minutes)
  4. Not considering concurrent Chlamydia infection when treating gonorrhea

Following these evidence-based guidelines for ceftriaxone dosing and duration will help ensure optimal treatment outcomes while minimizing the risk of adverse effects and antimicrobial resistance.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.